
Neurocrine Biosciences Inc
NASDAQ:NBIX

Intrinsic Value
The intrinsic value of one
NBIX
stock under the Base Case scenario is
129.09
USD.
Compared to the current market price of 124.61 USD,
Neurocrine Biosciences Inc
is
Undervalued by 3%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Neurocrine Biosciences Inc
Fundamental Analysis

Neurocrine Biosciences’ heavy reliance on Ingrezza for the bulk of its revenue leaves the company vulnerable should sales or market share of this core product decline, exposing a significant revenue concentration risk.
Ingrezza continues to show strong sales momentum, fueled by expanding market penetration for tardive dyskinesia and steady physician adoption, supporting robust cash flows.

Revenue & Expenses Breakdown
Neurocrine Biosciences Inc
Balance Sheet Decomposition
Neurocrine Biosciences Inc
Current Assets | 1.6B |
Cash & Short-Term Investments | 943.5m |
Receivables | 516m |
Other Current Assets | 178.4m |
Non-Current Assets | 2B |
Long-Term Investments | 909.5m |
PP&E | 589.2m |
Intangibles | 36.4m |
Other Non-Current Assets | 514.7m |
Free Cash Flow Analysis
Neurocrine Biosciences Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Neurocrine Biosciences Inc
Revenue
|
2.4B
USD
|
Cost of Revenue
|
-35.7m
USD
|
Gross Profit
|
2.4B
USD
|
Operating Expenses
|
-1.9B
USD
|
Operating Income
|
501.4m
USD
|
Other Expenses
|
-195.6m
USD
|
Net Income
|
305.8m
USD
|
NBIX Profitability Score
Profitability Due Diligence
Neurocrine Biosciences Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Score
Neurocrine Biosciences Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
NBIX Solvency Score
Solvency Due Diligence
Neurocrine Biosciences Inc's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

Score
Neurocrine Biosciences Inc's solvency score is 89/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NBIX Price Targets Summary
Neurocrine Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
NBIX
is 160.68 USD
with a low forecast of 116.15 USD and a high forecast of 201.6 USD.
Dividends
Current shareholder yield for NBIX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
NBIX
stock under the Base Case scenario is
129.09
USD.
Compared to the current market price of 124.61 USD,
Neurocrine Biosciences Inc
is
Undervalued by 3%.